198967-26-9

Basic information

• Product Name: Benzamide, 2,5-difluoro-N-methoxy-N-methyl-
• CAS NO: 198967-26-9
• Molecular Formula: C9H9F2NO2
• Molecular Weight: 201.173
• Mol File: 198967-26-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzamide, 2,5-difluoro-N-methoxy-N-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, 2,5-difluoro-N-methoxy-N-methyl-(198967-26-9)
• EPA Substance Registry System: Benzamide, 2,5-difluoro-N-methoxy-N-methyl-(198967-26-9)

Safety Data

• Hazardous Substances Data: 198967-26-9(Hazardous Substances Data)

Upstream product

• 35730-09-7 2,5-difluorobenzoyl chloride 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 399-94-0 2-bromo-1,4-difluorobenzene 
• 201230-82-2 carbon monoxide 

Downstream Products

• 873805-93-7 1-(2,5-difluorophenyl)-6-(tetrahydro-2H-pyran-2-yloxy)hex-2-yn-1-one 
• 877862-83-4 (E)-1-(2,5-difluorophenyl)-3-phenylprop-2-en-1-one 
• 873776-30-8 (2E)-1-(2,5-difluorophenyl)-3-phenylbut-2-en-one 
• 912917-43-2 C₁₅H₁₄F₂O₃ 
• 873776-31-9 (2Z)-1-(2,5-difluorophenyl)-3-phenyl-4-(tetrahydro-2H-pyran-2-yloxy)but-2-en-1-one 
• 873805-94-8 C₂₃H₂₄F₂O₃ 

Relevant articles and documents

Palladium-catalyzed carbonylation reactions of aryl bromides at atmospheric pressure: A general system based on xantphos

(Chemical Equation Presented) A method for the Pd-catalyzed carbonylation of aryl bromides has been developed using Xantphos as the ligand. This method is effective for the direct synthesis of Weinreb amides, 1° and 2° benzamides, and methyl esters from the corresponding aryl bromides at atmospheric pressure. In addition, a putative catalytic intermediate, (Xanphos)Pd(Br)benzoyl, was prepared and an X-ray crystal structure was obtained revealing an unusual cis-coordination mode of Xantphos in this palladium-acyl complex.

MITOTIC KINESIN INHIBITORS

The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to composition

MITOTIC KINESIN INHIBITORS

The present invention relates to fluorinated dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to